2-73849384-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_213622.4(STAMBP):​c.764G>A​(p.Arg255His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00113 in 1,614,002 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R255C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00089 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 7 hom. )

Consequence

STAMBP
NM_213622.4 missense

Scores

3
3
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 9.95

Publications

10 publications found
Variant links:
Genes affected
STAMBP (HGNC:16950): (STAM binding protein) Cytokine-mediated signal transduction in the JAK-STAT cascade requires the involvement of adaptor molecules. One such signal-transducing adaptor molecule contains an SH3 domain that is required for induction of MYC and cell growth. The protein encoded by this gene binds to the SH3 domain of the signal-transducing adaptor molecule, and plays a critical role in cytokine-mediated signaling for MYC induction and cell cycle progression. Multiple alternatively spliced transcript variants encoding the same protein isoform have been found for this gene. [provided by RefSeq, Jul 2008]
STAMBP Gene-Disease associations (from GenCC):
  • microcephaly-capillary malformation syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014479995).
BP6
Variant 2-73849384-G-A is Benign according to our data. Variant chr2-73849384-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 436880.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000894 (136/152196) while in subpopulation NFE AF = 0.0014 (95/68024). AF 95% confidence interval is 0.00117. There are 1 homozygotes in GnomAd4. There are 59 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 7 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STAMBPNM_213622.4 linkc.764G>A p.Arg255His missense_variant Exon 6 of 10 ENST00000394070.7 NP_998787.1 O95630-1A0A140VK54

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STAMBPENST00000394070.7 linkc.764G>A p.Arg255His missense_variant Exon 6 of 10 1 NM_213622.4 ENSP00000377633.2 O95630-1

Frequencies

GnomAD3 genomes
AF:
0.000894
AC:
136
AN:
152078
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00231
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00140
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00103
AC:
260
AN:
251338
AF XY:
0.00105
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.000867
Gnomad ASJ exome
AF:
0.00268
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00155
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00116
AC:
1695
AN:
1461806
Hom.:
7
Cov.:
31
AF XY:
0.00118
AC XY:
855
AN XY:
727210
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33470
American (AMR)
AF:
0.00107
AC:
48
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00279
AC:
73
AN:
26130
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39694
South Asian (SAS)
AF:
0.000406
AC:
35
AN:
86258
European-Finnish (FIN)
AF:
0.000168
AC:
9
AN:
53416
Middle Eastern (MID)
AF:
0.00278
AC:
16
AN:
5748
European-Non Finnish (NFE)
AF:
0.00129
AC:
1434
AN:
1111980
Other (OTH)
AF:
0.00126
AC:
76
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
93
186
280
373
466
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000894
AC:
136
AN:
152196
Hom.:
1
Cov.:
32
AF XY:
0.000793
AC XY:
59
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41518
American (AMR)
AF:
0.00118
AC:
18
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00231
AC:
8
AN:
3466
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00140
AC:
95
AN:
68024
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00133
Hom.:
0
Bravo
AF:
0.00114
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00198
AC:
17
ExAC
AF:
0.00116
AC:
141
EpiCase
AF:
0.00262
EpiControl
AF:
0.00249

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

STAMBP: BP4, BS2 -

not specified Uncertain:1
Feb 19, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcephaly-capillary malformation syndrome Benign:1
Oct 28, 2020
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.44
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Pathogenic
0.25
CADD
Pathogenic
33
DANN
Pathogenic
1.0
Eigen
Uncertain
0.58
Eigen_PC
Uncertain
0.52
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Benign
0.30
T
M_CAP
Benign
0.056
D
MetaRNN
Benign
0.014
T
MetaSVM
Benign
-0.31
T
PhyloP100
10
PROVEAN
Benign
0.16
N
REVEL
Benign
0.26
Sift
Benign
0.16
T
Sift4G
Benign
0.31
T
Vest4
0.32
MVP
0.73
ClinPred
0.11
T
GERP RS
4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.77
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146601260; hg19: chr2-74076511; COSMIC: COSV59898063; COSMIC: COSV59898063; API